Phil Gattone, M.Ed., was named president and chief executive officer of the National Bleeding Disorders Foundation (NBDF) in February 2024. He is an organizational leader and communicator with decades of experience understanding the dynamics of a national organization and a chapter network.
Gattone was president and CEO of the Epilepsy Foundation of America (EFA) from 2012-2019. Under Gattone’s leadership and vision, the EFA experienced record growth in community engagement, strategic partnerships, marketing, programming, and fundraising. In less than 10 years during Gattone’s time as CEO, the EFA’s annual revenues expanded by more than $15 million.
Additionally, Gattone successfully built alliances with multiple community partners, elevating the EFA’s position within the national and global epilepsy community. He introduced new cost-effective solutions that elevated mission impact and united the foundation. For his work, the EFA established the Phil Gattone Award for Exemplary Service to recognize his lifetime of significant achievements.
Before the EFA, Gattone spent three decades as a physician, researcher, and founder and director of the Hemophilia Thrombophilia Center at Rush University Medical Center in Chicago. Gattone has elevated community impact, serving as senior executive in local, regional, national, and global nonprofit organizations and health care companies. He has also led numerous clinical trials and published more than 150 papers on hemophilia and other bleeding disorders.
Gattone received his bachelor’s degree in business and marketing in 1981 from Bradley University in Peoria, Ill., and his master’s degree in education in 2000 from National Louis University in Chicago.
